Literature DB >> 18250953

A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides.

A Hishimoto1, H Cui, K Mouri, H Nushida, Y Ueno, K Maeda, O Shirakawa.   

Abstract

A recent linkage study suggested that a putative locus for suicidal behavior independent of psychiatric disease phenotypes lies at 5' upstream of the micro-opioid receptor (OPRM1) gene. We explored an association between suicide and genetic variations of the OPRM1 using a case-control study of 183 completed suicides and 374 control subjects. We genotyped four single nucleotide polymorphisms (SNPs) including a common A118G SNP. The genotypic and allelic distributions of the A118G SNP were significantly different between the completed suicide and control groups (P = 0.014 and 0.039, respectively). A dominant model analysis of the A118G SNP showed an enhanced association with suicide (P = 0.0041, Odds ratio 0.575) and this significant association was observed with a logistic regression analysis that takes sex and age factors into account (P = 0.021). Our results raise the possibility that the A118G SNP of the OPRM1 gene is associated with suicide.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250953     DOI: 10.1007/s00702-007-0853-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  44 in total

1.  Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects.

Authors:  J Gelernter; H Kranzler; J Cubells
Journal:  Mol Psychiatry       Date:  1999-09       Impact factor: 15.992

Review 2.  Neurobiology of suicidal behaviour.

Authors:  J John Mann
Journal:  Nat Rev Neurosci       Date:  2003-10       Impact factor: 34.870

3.  Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations.

Authors:  Ene-Choo Tan; Chay-Hoon Tan; Umavathy Karupathivan; Eric P H Yap
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

4.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

5.  Relationship between plasma adrenocorticotropin, hypothalamic opioid tone, and plasma leptin.

Authors:  G S Wand; H Schumann
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

6.  Regionally selective increases in mu opioid receptor density in the brains of suicide victims.

Authors:  R Gross-Isseroff; K A Dillon; M Israeli; A Biegon
Journal:  Brain Res       Date:  1990-10-22       Impact factor: 3.252

Review 7.  The neurobiology of suicide.

Authors:  J J Mann
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

8.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 9.  A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior.

Authors:  M Anguelova; C Benkelfat; G Turecki
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

10.  Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.

Authors:  G J Gwynn; E F Domino
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

View more
  15 in total

Review 1.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 2.  An overview of the neurobiology of suicidal behaviors as one meta-system.

Authors:  M Sokolowski; J Wasserman; D Wasserman
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

3.  Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals.

Authors:  Albert J Arias; Grace Chan; Joel Gelernter; Lindsay Farrer; Henry R Kranzler
Journal:  Am J Addict       Date:  2011-12-15

4.  Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.

Authors:  Saifeldin Mahmoud; Annika Thorsell; Wolfgang H Sommer; Markus Heilig; Joan K Holgate; Selena E Bartlett; Victor Ruiz-Velasco
Journal:  Anesthesiology       Date:  2011-11       Impact factor: 7.892

5.  Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependence.

Authors:  Darlene A Kertes; Gursharan Kalsi; Carol A Prescott; Po-Hsiu Kuo; Diana G Patterson; Dermot Walsh; Kenneth S Kendler; Brien P Riley
Journal:  Alcohol Clin Exp Res       Date:  2010-12-08       Impact factor: 3.455

6.  Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients.

Authors:  Martin A Kohli; Daria Salyakina; Andrea Pfennig; Susanne Lucae; Sonja Horstmann; Andreas Menke; Stefan Kloiber; Johannes Hennings; Bekh B Bradley; Kerry J Ressler; Manfred Uhr; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Arch Gen Psychiatry       Date:  2010-02-01

7.  The Role of Opiates in Social Pain and Suicidal Behavior.

Authors:  Benedicte Nobile; Pierre-Eric Lutz; Emilie Olie; Philippe Courtet
Journal:  Curr Top Behav Neurosci       Date:  2020

8.  Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population.

Authors:  A F Manini; M M Jacobs; D Vlahov; Y L Hurd
Journal:  J Med Toxicol       Date:  2013-06

9.  OPRM1 gene variants modulate amphetamine-induced euphoria in humans.

Authors:  A M Dlugos; A Hamidovic; C Hodgkinson; P H Shen; D Goldman; A A Palmer; H de Wit
Journal:  Genes Brain Behav       Date:  2010-11-02       Impact factor: 3.449

10.  Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Authors:  A B Niculescu; D F Levey; P L Phalen; H Le-Niculescu; H D Dainton; N Jain; E Belanger; A James; S George; H Weber; D L Graham; R Schweitzer; T B Ladd; R Learman; E M Niculescu; N P Vanipenta; F N Khan; J Mullen; G Shankar; S Cook; C Humbert; A Ballew; M Yard; T Gelbart; A Shekhar; N J Schork; S M Kurian; G E Sandusky; D R Salomon
Journal:  Mol Psychiatry       Date:  2015-08-18       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.